BioMarin adds Bristol Myers Squibb research chief to its board
Go back to BioMarin adds Bristol Myers Squibb research chief to its board| BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) | Delayed: 62.35 -1.02 (1.61%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $63.37 | 52 Week High | $108.96 | |||
| Open | $63.68 | 52 Week Low | $62.12 | |||
| Day High | $64.00 | P/E | N/A | |||
| Day Low | $61.94 | EPS | $-1.27 | |||
| Volume | 523,817 | |||||
